BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3084668)

  • 21. Herpes Simplex Virus Type 1 infection: overview on relevant clinico-pathological features.
    Arduino PG; Porter SR
    J Oral Pathol Med; 2008 Feb; 37(2):107-21. PubMed ID: 18197856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infections with herpes simplex viruses (2).
    Corey L; Spear PG
    N Engl J Med; 1986 Mar; 314(12):749-57. PubMed ID: 3005859
    [No Abstract]   [Full Text] [Related]  

  • 23. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up of interferon treatment of herpes simplex.
    Haverkos HW; Pazin GJ; Armstrong JA; Ho M
    N Engl J Med; 1980 Sep; 303(12):699-700. PubMed ID: 6157087
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy for herpes simplex virus infections.
    Erlich KS; Mills J
    West J Med; 1985 Nov; 143(5):648-55. PubMed ID: 3909643
    [No Abstract]   [Full Text] [Related]  

  • 26. Chloramphenicol in treatment of primary herpetic stomatitis and herpes labialis.
    ZEGARELLI EV; BUDOWSKY J; SILVERS HF; KUTSCHER AH
    AMA Arch Derm Syphilol; 1953 Jun; 67(6):635-6. PubMed ID: 13050191
    [No Abstract]   [Full Text] [Related]  

  • 27. Cutaneous herpes simplex infections and their treatment.
    Curry SS
    Cutis; 1980 Jul; 26(1):41-58. PubMed ID: 6248294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection.
    Burchett SK; Corey L; Mohan KM; Westall J; Ashley R; Wilson CB
    J Infect Dis; 1992 May; 165(5):813-8. PubMed ID: 1314868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transfer factor in the treatment of herpes simplex types 1 and 2.
    Khan A; Hansen B; Hill NO; Loeb E; Pardue AS; Hill JM
    Dermatologica; 1981; 163(2):177-85. PubMed ID: 6974662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral recrudescent herpes simplex virus infection.
    Woo SB; Lee SF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Feb; 83(2):239-43. PubMed ID: 9117756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of the herpes simplex viruses.
    Rawls WE; Hammerberg O
    Clin Dermatol; 1984; 2(2):29-45. PubMed ID: 6400315
    [No Abstract]   [Full Text] [Related]  

  • 32. Sodium hypochlorite: a useful therapeutic adjunct for herpes simplex infections.
    Hunter DT
    J Am Med Womens Assoc (1972); 1984; 39(4):135-6. PubMed ID: 6747177
    [No Abstract]   [Full Text] [Related]  

  • 33. Spontaneous and induced interferon production by peripheral blood leucocytes from control population and patients with herpes genitalis.
    Iannello D; Taylor MW; Fife KH; Chen L
    J Med Virol; 1987 May; 22(1):25-34. PubMed ID: 3035077
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune inhibition of virus release from herpes simplex virus-infected cells by human sera.
    Shariff DM; Hallworth J; Desperbasques M; Buchan A; Skinner GR
    Intervirology; 1988; 29(3):125-32. PubMed ID: 2846463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Management of cutaneo-mucosal herpes in immunocompetent patients (ocular manifestations excluded)].
    Agence Nationale d' Accréditation et d' Evaluation en Sante'
    Presse Med; 2002 Mar; 31(8):363-70. PubMed ID: 11913082
    [No Abstract]   [Full Text] [Related]  

  • 36. A prospective study of chronic herpes simplex virus infection and recurrent herpes labialis in humans.
    Douglas RG; Couch RB
    J Immunol; 1970 Feb; 104(2):289-95. PubMed ID: 4312871
    [No Abstract]   [Full Text] [Related]  

  • 37. Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections.
    Green JA; Weiss PN; Yeh TJ; Spruance SL
    J Med Virol; 1985 Jul; 16(3):297-305. PubMed ID: 2993500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Herpes simplex virus infections].
    Kunkel M; Gärtner L; Oberender H
    Z Gesamte Inn Med; 1985 Apr; 40(7):189-93. PubMed ID: 4039869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Indices of the immune status of recurrent herpes patients being treated with a herpes polyvaccine].
    Belokrinitskiĭ DV; Karpovich LG; Barinskiĭ IF; Bukovskaia SN; Semenova TB
    Vopr Virusol; 1987; 32(2):229-33. PubMed ID: 3037800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cycloferon and management of herpes virus infection].
    Alimbarova LM
    Antibiot Khimioter; 2014; 59(3-4):22-9. PubMed ID: 25300118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.